Skip to main content Skip to main navigation
Rijksoverheid logo | to homepage of RIVM National Institute for Public Health and the Environment Ministry of Health, Welfare and Sport
  • Nederlands
  • English
RIVM Committed to health and sustainability
  • Home
  • Topics
  • About RIVM
  • Publications
  • International
  • Contact
  • Agenda
  • MijnRIVM
  • Nederlands
  • English
  • Home
  • Page

Page

Back to topic

Articles Environment and Safety 2022

Articles Infectious Diseases and Vaccinology 2022

News about STIs

FAQ about cervical cancer screening on Saba

Research lines on tobacco and nicotine products

RIVM has built considerable expertise in the field of tobacco and nicotine product regulatory research. We perform a wide range of literature, data and analytical analyses on relevant parameters in tobacco and nicotine products and their emissions. Our main focus is on new products. Our research on tobacco and nicotine products follows four main research lines.

FAQ about breast cancer screening on Sint Eustatius

Breast cancer screening on Sint Eustatius

Cervical cancer screening on Sint Eustatius

Cervical cancer is a malignant tumor of the cervix. This form of cancer develops very slowly and is caused by a long-lasting infection with a virus: the human papillomavirus (HPV).

Harmful components in products and their emissions

A number of harmful substances in tobacco- and nicotine products and their emissions are measured at RIVM to support risk assessments, ongoing research, and regulation. This webpage provides a brief description of some of the harmful components in tobacco products.

Pagination

  • « « First
  • ‹ ‹ Previous
  • …
  • Page 37
  • Page 38
  • Page 39
  • Page 40
  • Current page 41
  • Page 42
  • Page 43
  • Page 44
  • Page 45
  • …
  • › Next ›
  • » Last »

Service

  • Contact
  • Information for the press
  • Working for RIVM
  • Complaints
  • Submitting WOO requests to RIVM
  • Doing business with RIVM
  • Social media house rules

About this site

  • Cookies
  • Privacy
  • Accessibility
  • Disclaimer and copyright
  • Coordinated Vulnerability Disclosure
  • Website archive

Languages

  • English
  • Nederlands

Follow us

  • RIVM Newsletters
  • RSS feed
  • X Twitter
  • Facebook
  • LinkedIn
  • Youtube
  • Instagram
  • Mastodon